Identification of structure–activity relationships for adverse effects of pharmaceuticals in humans. Part A: Use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicities
What others say about PharmaPendium
Identification of structure–activity: Part A
Tue, 08/07/2008
Identification of structure–activity: Part B
Wed, 09/07/2008
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities (2 parts on SD)
Mapping Adverse Drug Reactions in Chemical Space
Mon, 20/04/2009
Find out how the authors of ‘Mapping Adverse Drug Reactions in Chemical Space’ published in the Journal of Medicinal Chemistry in April 2009, used PharmaPendium in their research and analysis into adverse drug reactions in chemical space.
PharmaPendium. Make informed drug development decisions.
Interested? Contact us today to find out more about how PharmaPendium could benefit you.
News & Events
The December content release includes the following updates:
Year-To-Date EMA and FDA statistics:...
Who uses PharmaPendium?
PharmaPendium is an invaluable resource for anyone involved in drug development. Discover who uses PharmaPendium
What is PharmaPendium?
PharmaPendium is a powerful online decision support and analysis tool. See how you can make more informed drug development decisions
Watch our video to find out how.